Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and HIV Coinfection

3,4-dihydroxyphenylacetic acid has been researched along with HIV Coinfection in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Obermann, M2
Küper, M1
Kastrup, O1
Yaldizli, O1
Esser, S1
Thiermann, J1
Koutsilieri, E2
Arendt, G2
Diener, HC1
Maschke, M2
Scheller, C1
Nolting, T1
Antke, C1
Sopper, S1
Angerer, A1
Husstedt, IW1
Meisner, F1
Neuen-Jacob, E1
Müller, HW1
Carey, P1
Ter Meulen, V1
Riederer, P1

Other Studies

2 other studies available for 3,4-dihydroxyphenylacetic acid and HIV Coinfection

ArticleYear
Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV.
    Journal of neurology, 2009, Volume: 256, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; CD4 Lymphocyte Count; Chromatography, High Pressure Liq

2009
Increased dopaminergic neurotransmission in therapy-naïve asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses.
    Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Benzamides; Case-Control Studies; CD4 Antigens; Chemokine CCL

2010